XBiotech Inc (XBIT)

XBiotech Inc (XBIT) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $65.9M; returns 1 day -2.0%, 1 week -9.0%, 1 year -21.5%.

XBiotech Inc. is a clinical-stage biopharmaceutical company headquartered in Austin, Texas, specializing in the discovery and development of True Human monoclonal antibodies. These antibodies, derived from natural human immunity, are being developed to treat various diseases, including cancer, rheumatological, and infectious diseases.

Groups XBIT belongs to

• Biotechnology
• Biopharmaceutical
• Clinical Stage
• Clinical Stage Biotech
• Monoclonal Antibodies
• Healthcare
• Antibody Therapeutics
• Drug Discovery
• Life Sciences
• Oncology
• Cancer Therapeutics

XBIT financial model: income statement, cash flow and balance sheet